Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Amendments Act Implementation Faces Delay; Agency To Miss Deadlines

Executive Summary

FDA is expected to miss a spate of implementation deadlines for provisions of the FDA Amendments Act as the law approaches its first anniversary

You may also be interested in...



FDA Priority Review Voucher Guidance Coming: Incentive Has Low Visibility

FDA is planning a public meeting to discuss the new priority review voucher system to begin implementing the new program

FDA Priority Review Voucher Guidance Coming: Incentive Has Low Visibility

FDA is planning a public meeting to discuss the new priority review voucher system to begin implementing the new program

FDA Amendments Act’s One-Year Anniversary: For Better Or Worse

At the one-year anniversary of the FDA Amendments Act, the agency's record is mixed in meeting its increased responsibilities and authorities the law requires

Related Content

UsernamePublicRestriction

Register

PS050091

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel